Search for: "First Agency, Inc." Results 241 - 260 of 9,903
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jan 2024, 7:09 am by Melissa Tremblay
  When corporations choose to supply the American military and American government agencies with goods, the law is clear: we expect those goods to be American made.  When companies fail in their legal duty by substituting foreign products for the U.S. [read post]
16 Jan 2024, 12:30 pm by Amy Howe
Apparently because of Jackson’s recusal, the court added Relentless, Inc. v. [read post]
16 Jan 2024, 9:34 am by Rebecca Tushnet
“[M]ere deliberate agency inaction—an agency decision not to regulate an issue—will not alone preempt state law. [read post]
12 Jan 2024, 8:35 am by jeffreynewmanadmin
Attorney Newman can be reached at Jeff@Jeffnewmanlaw.com or at 617-823-3217 The post Treasury reveals and designates entities shipping or financing Houthis and Qods force for Iran appeared first on Jeff Newman Law. [read post]
11 Jan 2024, 2:58 pm by Guest Author
  We base our analysis on our experience as Commissioners of the Federal Communications Commission (FCC), an independent agency charged by Congress with promoting a vibrant and diverse media ecosystem consistent with the First Amendment. [read post]
11 Jan 2024, 11:15 am by Logan Castellanos
The lack of approvals from 2018 to 2021 is in stark contrast to the prior operations of Mexico’s regulatory agencies, which had previously approved 181 applications, half of which (90) were related to corn. [read post]
11 Jan 2024, 11:15 am by Logan Castellanos
The lack of approvals from 2018 to 2021 is in stark contrast to the prior operations of Mexico’s regulatory agencies, which had previously approved 181 applications, half of which (90) were related to corn. [read post]
11 Jan 2024, 12:03 am by Kurt R. Karst
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]